Addressing Management Challenges Posed by Patients with Severe Uncontrolled Asthma in Clinical Practice: A Situation Room for Pulmonologists and Otolaryngologists
Please note: The webGL technology used in this activity ONLY supports Chrome, Microsoft EDGE (IE replacement) and FireFox. Please be sure to view activity on one of those three browsers.
Go to Pulmonary Track
Mario Castro, MD, MPH
Pulmonary, Critical Care and Sleep Medicine
Vice Chair for Clinical and Translational Research
Director of the Rainbow Clinical Trials Science Unit,
University of Kansas School of Medicine
Kansas City, Kansas
This online activity is focused on the team involved in the management of patients with asthma.
This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists, and otolaryngologists involved in the health care of patients with severe uncontrolled asthma.
Upon completion of the CE activity, learners should be better able to:
- Review asthma phenotypes and their role in the development of targeted treatments for severe uncontrolled asthma
- Assess evidence regarding the use of phenotype- or endotype-specific biomarkers for diagnosing, classifying, and controlling asthma
- Apply evidence-based guidance, clinical profiles of current treatments, and patient-specific factors to individualize treatment plans for patients with severe uncontrolled asthma
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the treatment and management of patients with uncontrolled asthma.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education for RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Mario Castro, MD has received royalties from Elsevier. Dr. Castro has received consulting fees from Genentech, Teva, Novartis, Sanofi-Aventis, Theravance, and VIDA. Dr. Castro discloses that he is on the speakers’ bureaus for AstraZeneca, Genentech, GlaxoSmithKline, Regeneron and Sanofi-Aventis. Dr. Castro has received contracted research from AstraZeneca, Chiesi, GlaxoSmithKline, Novartis and Sanofi-Aventis.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Melissa A Johnson, Sr. Program Manager of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Diana Tommasi, Medical Director of Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.
Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
RELEASE DATE: February 28, 2020
EXPIRATION DATE: February 28, 2021
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.